Active Not Recruiting OBSERVATIONAL NCT04863924

Accelerating Lung Cancer Diagnosis Through Liquid Biopsy (ACCELERATE)

Sponsor: Lung Health Foundation

Updated 10 times since 2021 Last updated: Dec 11, 2025 Started: Jan 14, 2021 Primary completion: Jul 25, 2023 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Non-small Cell Lung Cancer and is currently ongoing. Lung Health Foundation leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Active Not Recruiting
Feb 2025 — Jan 2026 [monthly]

Active Not Recruiting
Sep 2024 — Feb 2025 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Apr 2024 — Jul 2024 [monthly]

Active Not Recruiting

▶ Show 5 earlier versions

Dec 2023 — Apr 2024 [monthly]

Active Not Recruiting
Mar 2023 — Dec 2023 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Feb 2023 — Mar 2023 [monthly]

Recruiting
Jun 2022 — Feb 2023 [monthly]

Recruiting
May 2021 — Jun 2022 [monthly]

Recruiting

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lung Health Foundation
The Princess Margaret Cancer Foundation
University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada